Journal article
Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)
Abstract
Hypertension is a risk factor for both progression of atrial fibrillation (AF) and development of AF-related complications, that is major adverse cardiac and cerebrovascular events (MACCE). It is unknown whether left ventricular hypertrophy (LVH) as a consequence of hypertension is also a risk factor for both these end points. We aimed to assess this in low-risk AF patients, also assessing gender-related differences. We included 799 patients …
Authors
Erküner Ö; Dudink EAMP; Nieuwlaat R; Rienstra M; Van Gelder IC; Camm AJ; Capucci A; Breithardt G; LeHeuzey J-Y; Lip GYH
Journal
The American Journal of Cardiology, Vol. 122, No. 4, pp. 578–583
Publisher
Elsevier
Publication Date
August 2018
DOI
10.1016/j.amjcard.2018.04.053
ISSN
0002-9149
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Age DistributionAtrial FibrillationBlood PressureComorbidityDisease ProgressionEchocardiographyElectrocardiography, AmbulatoryEuropeFemaleFollow-Up StudiesHeart RateHumansHypertensionHypertrophy, Left VentricularIncidenceMaleMiddle AgedPopulation SurveillancePrognosisRegistriesRetrospective StudiesRisk FactorsSex DistributionSurvival Rate